U.S. markets close in 13 minutes
  • S&P 500

    3,732.49
    +85.20 (+2.34%)
     
  • Dow 30

    29,783.13
    +648.14 (+2.22%)
     
  • Nasdaq

    11,087.09
    +257.58 (+2.38%)
     
  • Russell 2000

    1,721.62
    +59.11 (+3.56%)
     
  • Crude Oil

    82.08
    +3.58 (+4.56%)
     
  • Gold

    1,668.50
    +32.30 (+1.97%)
     
  • Silver

    18.90
    +0.56 (+3.07%)
     
  • EUR/USD

    0.9733
    +0.0135 (+1.41%)
     
  • 10-Yr Bond

    3.7050
    -0.2590 (-6.53%)
     
  • GBP/USD

    1.0885
    +0.0154 (+1.43%)
     
  • USD/JPY

    144.1410
    -0.6500 (-0.45%)
     
  • BTC-USD

    19,550.05
    +495.74 (+2.60%)
     
  • CMC Crypto 200

    445.26
    +16.48 (+3.84%)
     
  • FTSE 100

    7,005.39
    +20.80 (+0.30%)
     
  • Nikkei 225

    26,173.98
    -397.89 (-1.50%)
     

DaVita Inc. Schedules 2nd Quarter 2022 Investor Conference Call

·2 min read

DENVER, July 18, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Monday, August 1, 2022, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.

This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:

Monday, August 1, 2022
Starting at 5:00 p.m. ET
Dial in number: 877-918-6630
International dial in: 517-308-9042
Webcast: investors.davita.com

When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.

About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of March 31, 2022, DaVita served 200,800 patients at 2,809 outpatient dialysis centers in the United States. The company also operated 346 outpatient dialysis centers in 11 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

Contact Information 
Investors:
IR@davita.com

DaVita Logo (PRNewsfoto/DaVita)
DaVita Logo (PRNewsfoto/DaVita)

 

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-schedules-2nd-quarter-2022-investor-conference-call-301587942.html

SOURCE DaVita